Single answer
Is Hubei Jumpcan Pharmaceutical Co (600566.SS) a buy or sell?
4starter turns market data into one clear verdict you can act on.
Create a free account to save tickers and track your signals.
Log in to turn on watchlist alerts.
Decision snapshot
Everything you need to act fast, in one glance.
What is the conclusion?
Right now our advanced algorithms say:
Do analysts agree?
We compare consensus targets with today's price.
No analyst target data available for this ticker.
Company snapshot
A quick overview of the business and its public profile.
Hubei Jumpcan Pharmaceutical Co Ltd engages in the research development manufacturing and trading of Chinese traditional medicines western medicines daily use chemical based Chinese traditional medicines and Chinese medicine health products in China The company offers Chinese and western medicines in the areas of pediatrics gynecology pneumology gastroenterology and geriatrics oral and skin care products and antifatigue antiaging antioxidant and immunityenhancing Chinese medicine health products It also develops Chinese and western medicines in the areas of detoxification digestive system respiratory system nervous system antiinfection cardiovascular narcotic analgesic nutrition musculoskeletal and hemostasis The company was formerly known as Hubei Hongcheng General Machinery Co Ltd and changed its name to Hubei Jumpcan Pharmaceutical Co Ltd in March 2015 Hubei Jumpcan Pharmaceutical Co Ltd is based in Taixing China
Website: https://www.jumpcan.com
Rates and inflation backdrop
US inflation for November 2025 was 0.20%. Over the last 12 months, inflation is 3.00%. The 10-year yield is 4.18 and is down -0.0500 over the last 30 days.
Inflation sensitivity
Debt ratio: 0.05. Cash flow to debt ratio: 0.93. Net profit margin: 26.88%. Inflation risk score: low (0.00/1).
Dividend history check
Yes, Hubei Jumpcan Pharmaceutical Co pays dividends. Last payment was 2024-06-17 for holders on 2024-06-17. Over 20 payments between 2002 and 2024, total CNY 8.80 with an average of CNY 0.440 per share. Last dividend was CNY 1.300.
Trading liquidity
We do not have enough data to give you this answer.
10-year return check
No data available for investment message.
Why this answer
We combine price momentum, volatility, and trend signals to simplify the decision to one word.
Signal engine scans price, trend, and momentum indicators.
Targets and sentiment are checked against the live quote.
We keep the output simple: buy, sell, or hold.
Analyst consensus
How Wall Street targets compare to today's price.
No analyst target data available for this ticker.